Announced Tue, 29 Sept, 2026 · 11:30 IST
Subsidiary signs exclusive India deal with Korea CAREGEN for Korglutide brand
PLATIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.7%1-day move
₹206.30
prior close
₹207.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.4+0.3+0.0+0.7-1.8-1.1-0.2-3.0—————
Up moveDown movePending
AI summary
Platinum Industries' subsidiary Rivadu Lifesciences has signed an exclusive Sale/Purchase Agreement with Korea's CAREGEN Co. for the Indian market. The deal covers CAREGEN's health functional food products sold under the brand name Korglutide. Key terms include exclusive partnership for India territory and prospects for local manufacturing. The transaction is not a related party deal.
Likely market impact
Opens India market for Korean health food brand and possible future manufacturing. Could support subsidiary growth; no deal value disclosed.